Limit Ranibizumab Injections in Macular Degeneration

The lucky number is 7 — or 7.1 to be exact — the mean optimum number of injections of intravitreal ranibizumab (Lucentis, Genentech) that should be given during the first year of treatment for neovascular age-related macular degeneration, according to a new meta-analysis.

The results suggest that beyond 7 injections, there is little likelihood of additional gains in visual acuity, said Heinrich Gerding, MD, an ophthalmologist in the Department of Retinology at Pallas Clinic Olten in Switzerland.

for more info:


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: